Recombinant human erythropoietin therapy in end stage renal failure.
Watson
A J
AJ
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Spivak
J L
JL
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin